Suchergebnisse - "Zhong, Lian-Zhen"

PubPharm (8)

1

Radiomic signatures associated with tumor immune heterogeneity predict survival in locally recurrent nasopharyngeal carcinoma

enthalten in: Journal of the National Cancer Institute | 2024

von Lin, D. | Li, H. | Liu, T. | +17

2

Radiomic signatures reveal multiscale intratumor heterogeneity associated with tissue tolerance and survival in re-irradiated nasopharyngeal carcinoma : a multicenter study

enthalten in: BMC medicine | 2023

von Liu, T. | Dong, D. | Zhao, X. | +30

CommentIn: BMC Med. 2023 Nov 28;21(1):465. - PMID 38017483

3

Radiomic signatures reveal multiscale intratumor heterogeneity associated with tissue tolerance and survival in re-irradiated nasopharyngeal carcinoma: a multicenter study

enthalten in: BMC medicine | 2023

von Liu, T. | Dong, D. | Zhao, X. | +30

4

A deep learning MR-based radiomic nomogram may predict survival for nasopharyngeal carcinoma patients with stage T3N1M0

enthalten in: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology | 2020

von Zhong, L. | Fang, X. | Dong, D. | +8

5

A deep-learning-based prognostic nomogram integrating microscopic digital pathology and macroscopic magnetic resonance images in nasopharyngeal carcinoma : a multi-cohort study

enthalten in: Therapeutic advances in medical oncology | 2020

von Zhang, F. | Zhong, L. | Zhao, X. | +12

6

Development and validation of a novel MR imaging predictor of response to induction chemotherapy in locoregionally advanced nasopharyngeal cancer : a randomized controlled trial substudy (NCT01245959)

enthalten in: BMC medicine | 2019

von Dong, D. | Zhang, F. | Zhong, L. | +7

7

Development and validation of a novel MR imaging predictor of response to induction chemotherapy in locoregionally advanced nasopharyngeal cancer: a randomized controlled trial substudy (NCT01245959)

enthalten in: BMC medicine | 2019

von Dong, D. | Zhang, F. | Zhong, L. | +7

8

Development and validation of a novel MR imaging predictor of response to induction chemotherapy in locoregionally advanced nasopharyngeal cancer: a randomized controlled trial substudy (NCT01245959)

enthalten in: BMC medicine | 2019

von Dong, D. | Zhang, F. | Zhong, L. | +7

1
[1]